Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

46.67
Delayed Data
As of Aug 28
 +0.41 / +0.89%
Today’s Change
15.10
Today|||52-Week Range
56.18
+108.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash50.1M63.8M44.8M31.0M
 
 
 
 
 
Short Term Investment Cash-3.9M13.6M-19.0M-13.8M
 
 
 
 
 
Cash & Short Term Investments129.1M173.0M145.7M193.8M
 
 
 
 
 
 
ReceivablesReceivables1.9M14.1M23.0K--
 
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets1.5M2.2M2.7M4.4M
 
 
 
 
 
Current Assets132.5M189.3M148.5M198.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross36.5M36.2M30.1M31.3M
 
 
 
 
 
Depreciation-34.9M-34.3M-28.3M-28.7M
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets138.4M196.0M154.7M243.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.1M911.0K101.0K246.0K
 
 
 
 
 
Accrued Expenses4.6M4.3M4.6M5.0M
 
 
 
 
 
Other Current Liabilities42.2M10.9M8.2M8.9M
 
 
 
 
 
Other Liabilities47.1M15.6M11.7M15.7M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities4.3M3.2M2.9M2.5M
 
 
 
 
 
Total Liabilities78.3M41.6M34.3M34.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity60.1M154.4M120.4M208.7M
 
 
 
 
 
Total Shareholder Equity60.1M154.4M120.4M208.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding55.3M66.4M67.4M76.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.